1 / 26

MINAS GERAIS’ OVERVIEW: BIOTECHNOLOGY

MINAS GERAIS’ OVERVIEW: BIOTECHNOLOGY. Belo Horizonte. Brasília. Rio de Janeiro. São Paulo. Minas Gerais - Main figures. TERRITORY . 587,000 Km2 . Larger than countries such as France, Sweden, and Spain. ECONOMY . In 2009, increase was 7.5% (FJP) . G DP: US$ 143 billion

beatrice-cantu
Télécharger la présentation

MINAS GERAIS’ OVERVIEW: BIOTECHNOLOGY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MINAS GERAIS’ OVERVIEW: BIOTECHNOLOGY

  2. Belo Horizonte Brasília Rio de Janeiro São Paulo

  3. Minas Gerais - Main figures TERRITORY . 587,000 Km2 . Larger than countries such as France, Sweden, and Spain ECONOMY . In 2009, increase was 7.5% (FJP) . GDP: US$ 143 billion . Exports: 2011 – US$ 41,3 bi . Second largest industrial park of the country . A leader in Brazil for mining, metallurgy, coffee, dairy, biotechnology, engineering, management,consultancy,etc. SOCIAL . Population: around 20.0 million inhabitants . Children at school: 2,6 million . 18 thousand elementary schools INFRA-STRUCTURE . 265.000 km of roads (23.000km paved) . 5,329 km of railways . 66 airports – 1 international and industrial . 18,5% of total energy generation in Brazil . Broad telecom network: 4,15M fixed lines and 8,8M mobile lines

  4. Knowledge is responsible for 55% ofthe world capital. Organization for EconomicCooperationandDevelopment (OECD)

  5. ThePotentialofBiotechnology in Minas Gerais • Minas Gerais is the 2nd state in Brazilharboringbiotechnologicbasedcompanieswhichcomprises 30% ofthenational enterprises. • Minas Gerais hasimportantuniversitiessuch as UFMG andvariousresearchinstituteswith tradition in Human and Animal Medicine, Biochemistry, Pharmacy and Agronomy. • UFMG has more than 160 researchers with a Ph.D. in biological sciences and more than 60% of its patents are related to biotechnology. • Biotechnology is verypromising in termsoftechnologicaldevelopmentof Minas Gerais.

  6. Structutring Project: Biotechnology Cluster Source: State Secretariat of Science, Technology and Higher Education - SECTES Slides and information extracted from "SECTES Presentation". Autororized use

  7. Key Points • Innovation: provide environment for innovation. • Innovation in Business: actions and support cooperation between enterprises and institutions of science and technology. • Regional and Sectorial Development: increase the competitiveness of economic sectors with high technological content.

  8. Targets • Promote and coordinate research activities, development and innovation in biotechnology applied to human and animal health, agribusiness and environment, creating partnerships between academy and industry. • Promote and manage training programs to achieve competitive advantage focusing on market trends for the next 5 years: • Market reposition companies of biotechnology. • Merging different technologies: biotech, IT, electronics and engineering for development of new biotechnology products.

  9. DevelopedProducts BUREAU COMPETITIVENESS TRAINING MANAGEMENT IEL/FIEMG SEBRAE - MG MINAS BIOTECH CLUSTER MARKETING CERTIFICATION Sindusfarq Sindusfarq MINAS BIOPOLE CENTER OF EXCELLENCE IN BIOINFORMATICS Funed CPqRR – FiocruzMnas

  10. Starting Pointversus CurrentSituation

  11. Starting Pointversus CurrentSituation

  12. 81 Companies 30 Companies 32 Companies 19 Companies

  13. Business Segment • DistributionofCompaniesbysize: • RMBH : 70% are micro andsmall • TMAP: 58% are micro and small • Viçosa: 85% are micro and small

  14. Revenue

  15. Biotech Expertises CATTLE GENETICS HUMAN DIAGNOSTICS AGRIBUSINESS MICROELETRONICS & TELECOMS

  16. OTHERS TECNOLOGYCAL AND POLITICS INFRASTRUTURES

  17. Patents in BiotechnologyArea • Year: 2008 • UFMG – 101 patents, of which 10 were licensed • UFV – 34 patents, of which 5 were licensed • UFU – 16 patents, of which 3 are in the process of licensing • UFOP - 7 patents • EMBRAPA CORN AND SORGHUM – 2 patents

  18. Technological Parks Implementation

  19. Attraction of R&DCenters Politic of Attraction of R&D Centers Empresas Attraction of Enterprises: articulation of the key players involved in the attraction of R & D centers for the state of Minas Gerais

  20. Incubators 19 Incubators Supported

  21. PublicsUniversities FEDERAL UNIVERSITIES STATE UNIVERSITIES UNIMONTES UFVJM UFU FJP UEMG UFMG FHA UFTM UFOP UFV UNIFENAS UFSJ UFLA UFJF UNIFEI

  22. THINKING GLOBAL, ACTING LOCAL Proactive action in fund raising and establishment of international partnerships in order to support the development of Science, Technology, Innovation and Higher Education in Minas Gerais.

  23. Who is Tech Solutions? • High level of integrity, quality and honesty; • Customized projects development; • Expertise in several areas: • Biotechnology, • Energy, • Environment, • Information Technology, • Development and Project Management; • Consolidated network in the market and scientific enviroment; • TS conducts its operationsfrom Belo Horizonte-MG.

  24. ThankYou Dr. Roberto Machado Silva Mobile: 31 9967-5998

More Related